Cargando…
Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma
Uveal melanomas are rare tumors arising from melanocytes that reside in the eye. Despite surgical or radiation treatment, approximately 50% of patients with uveal melanoma will progress to metastatic disease, most often to the liver. Cell-free DNA (cfDNA) sequencing is a promising technology due to...
Autores principales: | Wong, Derek, Luo, Ping, Znassi, Nadia, Arteaga, Diana P., Gray, Diana, Danesh, Arnavaz, Han, Ming, Zhao, Eric Y., Pedersen, Stephanie, Prokopec, Stephenie, Sundaravadanam, Yogi, Torti, Dax, Marsh, Kayla, Keshavarzi, Sareh, Xu, Wei, Krema, Hatem, Joshua, Anthony M., Butler, Marcus O., Pugh, Trevor J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973415/ https://www.ncbi.nlm.nih.gov/pubmed/36860651 http://dx.doi.org/10.1158/2767-9764.CRC-22-0456 |
Ejemplares similares
-
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
por: Lheureux, Stephanie, et al.
Publicado: (2023) -
Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors
por: Kelly, Deirdre, et al.
Publicado: (2021) -
Heterogeneous alteration of the ERBB3–MYC axis associated with MEK inhibitor resistance in a KRAS-mutated low-grade serous ovarian cancer patient
por: Colombo, Ilaria, et al.
Publicado: (2019) -
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
por: Nabbi, Arash, et al.
Publicado: (2023) -
Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing
por: Chow, Signy, et al.
Publicado: (2022)